OTCMKTS:COTQF

Cotinga Pharmaceuticals News Headlines

$0.30

0.00 (0.00 %)

(As of 01/26/2021 12:00 AM ET)

Add

Today's Range

$0.30

Now: $0.30▼

$0.44

50-Day Range

$0.03

MA: $0.14▼

$0.60

52-Week Range

$0.01

Now: $0.30▼

$0.95

Volume9,240 shs

Average Volume1,976 shs

Market Capitalization$6.60 million

P/E RatioN/A

Dividend YieldN/A

Beta43.44

Source:

Source	Headline
	Cotinga Pharmaceuticals Inc. (OTCMKTS:COTQF) Short Interest Down 96.1% in December americanbankingnews.com - January 12 at 5:24 PM
	Cotinga Pharmaceuticals Reports Fiscal 2019 Third Quarter Financial and Operating Results www.globenewswire.com - April 6 at 10:30 AM
	Cotinga Pharmaceuticals Reports Fiscal 2019 Third Quarter Financial and Operating Results finance.yahoo.com - April 5 at 5:21 PM
	Cotinga Pharmaceuticals Doses First Patient in Second Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors finance.yahoo.com - February 26 at 11:17 AM
	Cotinga Pharmaceuticals Doses Cohort 1 Patients With Combination Therapy in Phase 1b/2a Trial of COTI-2 finance.yahoo.com - January 29 at 10:33 AM
	Cotinga Pharmaceuticals Doses First Patient With Combination Therapy in Phase 1b/2a Trial of COTI-2 finance.yahoo.com - January 15 at 10:15 AM

This page was last updated on 1/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.